Precision blood thinning therapy study
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 8 years or older (for the NOAC part) or 18 years or older (for the indobufen part).
- You have non-valvular atrial fibrillation, a blood clot in a vein (deep vein thrombosis) or lung (pulmonary embolism), or another condition needing a newer blood thinner (NOAC).
- You are currently taking one of these blood thinners: rivaroxaban, apixaban, dabigatran etexilate, or edoxaban.
- You have a high risk of bleeding within 72 hours of symptom onset and are starting indobufen for the first time after admission.
- You are willing to follow the study plan and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stopping and restarting a blood thinner (NOAC) in stages around your heart device implant surgery is safer than the standard approach. The goal is to reduce bleeding while keeping blood clots at bay.
This trial is testing whether a newer type of blood thinner (called a NOAC) can be used safely right after a heart attack or related event, in addition to the standard two antiplatelet medicines. It focuses on patients who have higher risk signs, like elevated D-dimer levels or a higher PARIS risk score, to see if this approach is safe and effective at preventing future heart problems.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This registry study looks at how people with atrial fibrillation (AF) or blood clots (VTE) use blood thinners, especially NOACs, over time. It may help doctors better understand real-world patterns of treatment and outcomes.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.